Preliminary Study of Anticoccidial Activity of Medium Chain Fatty Acids (MCFA) and their Corresponding Monoglycerides on Broiler Chicken Coccidiosis

Abstract

The effect of anticoccidial from oil containing medium chain fatty acids and their corresponding monoglycerides, which known as enhanced virgin coconut oil (EVCO) was investigated. A total of 100 broiler chicks were assigned to four treatment groups. Group A, B and C were infected with 8 species of live coccidia. Group A was then treated with 30% EVCO; Group B with antibiotic (Coccisul-Q) and no treatment for Group C. Group D as control. The birds infected with live coccidia (Group A, B and C) had significantly higher in the oocyst count and showed blood in droppings appeared after 7-day post-infection (DPI), except Group D. In Group A2 at 11-day post infection/4-day post treatment (DPI 11/ DPT 4), the number of oocyst count was dropped from 132,400 o/g to 600 o/g; and in Group B2 is about 75,600 o/g to 0 o/g. However, there was no significant reducing in Group C2. A significant deduction of oocysts level in faecal and cecal dramatically after 4 days post-treatment in group treated with EVCO. However, from the observation, the performance of EVCO was not as good as in the antibiotic treated group. Nevertheless, the EVCO is a plant-based compounds, it is good and safe to be used as alternative way to control coccidiosis in poultry industries. Therefore, for EVCO consumption, the treatment must be provided weekly for long lasting protection from coccidiosis.

Effect of dietary supplementation with medium chain fatty acids on growth performance, intestinal histomorphology, lipid profile and intestinal microflora of broiler chickens

“…Conversely, other studies showed no broiler performance improvement when birds received MCFAs in comparison with control birds and birds fed antibiotics (Gunal et al, 2006;Vieira et al, 2008). However, at the moment, numerous studies suggest that MCFAs have growth-promoting properties and can be used as alternatives to antibiotics and anticoccidiostats (Tan & Long, 2012;Khan & Iqbal, 2016).…”

“…It was reported that Aromabiotic decreased the invasion of enteric pathogens, decreased mortality and had positive effects on growth performance and intestinal histomorphology in broiler chickens (Khosravinia, 2015;Gutierrez et al, 2006) and Japanese quail (Saeidi et al, 2016). Numerous natural products, such as sources of fats containing high concentrations of n-3 fatty acids or feedstuffs, have been tested as anticoccidial dietary additives (Tan & Long, 2012). MCFAs have been found to have anticoccidial activity in calves and antiprotozoal activity in dairy cattle, swine, sheep, goat and infant animals (Tan & Long, 2012).…”

“…Numerous natural products, such as sources of fats containing high concentrations of n-3 fatty acids or feedstuffs, have been tested as anticoccidial dietary additives (Tan & Long, 2012). MCFAs have been found to have anticoccidial activity in calves and antiprotozoal activity in dairy cattle, swine, sheep, goat and infant animals (Tan & Long, 2012).…”

Enhanced Virgin Coconut Oil (EVCO) as Natural Postmilking Teat Germicide to Control Environmental Mastitis Pathogens

“…Candida albicans, C. krusei and Pityrosporumovale [18]. A preliminary study of anticoccidial activity of EVCO on broiler chicken coccidiosis showed a promising result with a significant reduction of oocysts level observed in faecal and cecal dramatically after 4 days posttreatment with EVCO [20], which has generally recognized as safe (GRAS) status and it can be a good and safer alternative way to control harmful pathogens. Prevention of new infection is a key strategy for mastitis control and milk quality management handling.…”

The antimicrobial activity of Enhanced Virgin Coconut Oil (EVCO) on growth of mastitis pathogens

“…In addition, a recent study on the effect of EVCO against coccidiosis in broiler chicken also showed promising results and can be used as an alternative way to control coccidiosis in the poultry industry (Tan and Long, 2012). The present study aims to determine the efficacy of EVCO against three potent mastitis causal agents, namely S. aureus (ATCC 31885), S. agalactiae (ATCC 12927) and S. dysagalactiae (ATCC 27957).…”